Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset Graves' disease treated with antithyroid drugs-Reference-Cited by-同舟云学术

Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset Graves' disease treated with antithyroid drugs

Published:2020-04 Issue:4 Volume:36 Page:281-286
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung Journal of Medical Sciences

Author:

Wang Shuo‐Yu¹^ORCID,Wang Chia‐Ti²,Tien Kai‐Jen³,Chang Chao‐Chun⁴,Liu Ting‐Hsiu⁵

Affiliation:

1. Department of PediatricsChi Mei Medical Center Tainan Taiwan

2. Department of EmergencyChi Mei Medical Center Tainan Taiwan

3. Division of Endocrinology and Metabolism, Department of Internal MedicineChi Mei Medical Center Tainan Taiwan

4. Radioimmunoassay Laboratory, Department of Nuclear MedicineChi Mei Medical Center Tainan Taiwan

5. Department of Medical ResearchChi Mei Medical Center Tainan Taiwan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12167

Reference27 articles.

1. The epidemiology of Graves' disease: Evidence of a genetic and an environmental contribution

2. Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016

3. Increasing Incidence of Juvenile Thyrotoxicosis in Denmark: A Nationwide Study, 1998-2012

4. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease;Journal of the Endocrine Society;2022-02-16

2. Hyperthyroidism in Children;Graves' Disease;2021-12-01

3. Methimazole-induced remission rates in pediatric Graves’ disease: a systematic review;European Journal of Endocrinology;2021-08-01

4. Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience;Frontiers in Endocrinology;2021-06-14